EverSource Wealth Advisors’s Maravai LifeSciences MRVI Stock Holding History

EverSource Wealth Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.32K	Buy	820 +25	+3%	+$85	﹤0.01%	3595
2025 Q4	$2.58K	Sell	795 -379	-32%	-$1.28K	﹤0.01%	3406
2025 Q3	$3.37K	Buy	1,174 +321	+38%	+$820	﹤0.01%	3318
2025 Q2	$2.06K	Sell	853 -190	-18%	-$399	﹤0.01%	3502
2025 Q1	$2.31K	Sell	1,043 -1,393	-57%	-$5.5K	﹤0.01%	2858
2024 Q4	$13.3K	Buy	2,436 +1,874	+333%	+$12.1K	﹤0.01%	1858
2024 Q3	$4.67K	Sell	562 -36	-6%	-$311	﹤0.01%	2254
2024 Q2	$5.82K	Buy	598 +22	+4%	+$190	﹤0.01%	2165
2024 Q1	$4.72K	Sell	576 -210	-27%	-$1.42K	﹤0.01%	2080
2023 Q4	$5.15K	Buy	+786	New	+$5.08K	﹤0.01%	1846

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EverSource Wealth Advisors's MRVI Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Maravai LifeSciences (MRVI) stake by 3.1% in Q1 2026, buying an estimated $85 and bringing the position to 820 shares worth $2.32K. The position accounts for ﹤0.01% of the portfolio, ranked #3595.

EverSource Wealth Advisors first reported a position in MRVI in Q4 2023 and has held it in 10 quarters since. The position peaked at $13.3K in Q4 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

EverSource Wealth Advisors held 820 shares of Maravai LifeSciences worth $2.32K as of Q1 2026.
EverSource Wealth Advisors bought 25 Maravai LifeSciences shares in Q1 2026, an estimated $85.
Maravai LifeSciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3595 holding.
EverSource Wealth Advisors first reported a position in Maravai LifeSciences in Q4 2023 and has held it in 10 quarters since.
EverSource Wealth Advisors's Maravai LifeSciences position peaked at $13.3K in Q4 2024.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.